Insider filing · OSCR

Thrive Partners VII Growth GP, LLC bought $14.4M of Oscar Health (OSCR)

Executed Nov 11 2024, disclosed Nov 13 2024, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Nov 13 2024), the stock returned +0.5% (delay-adjusted); from the execution session (Nov 11 2024), +9.5%. Derived: entry at the session's open, exit at the close 20 sessions later.

TL Thrive Partners VII Growth GP, LLC Director profile →

Thrive Partners VII Growth GP, LLC (Director) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales), most often in Oscar Health, Inc. (OSCR). Across 2 priced purchase filings, the average 21-session return was -8.2% from execution and -8.0% from disclosure (delay-adjusted; derived). The largest single filing was $14.4M of OSCR (1,055,478 sh across 3 lots, as filed), executed Nov 11 2024.

OSCR Oscar Health, Inc. OSCR · Healthcare · 46 filings in 24 months ticker →

Healthcare · Oscar Health, Inc. operates as a healthcare technology company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→